课题基金 / 基金详情

The MIcroRnas and Congenital Lung Anomalies program: MIRACLA

The MIcroRnas and Congenital Lung Anomalies program: MIRACLA
微生物和先天性肺异常项目:MIRACLA
批准号:
270213
负责人:
Keijzer Richard
金额:
$10.93万
依托单位国家:
加拿大
项目类别:
Salary Programs
财政年份:
2012
资助国家:
加拿大
项目状态:
已结题
起止时间:
2012-09-01 至 2017-09-01

项目摘要

项目成果

Keijzer Richard的其他基金

相似基金

相关文献

中文摘要
翻译
在加拿大,每年有多达100名儿童出生时患有先天性腹股沟疝(CDH)。我的小组以前的研究表明,与肺缺陷相关的异常肺发育是导致不良结局的原因。
英文摘要
Every year up to one hundred children are born in Canada with a congenital diaphragmatic hernia (CDH). Previous research from my group has shown that the abnormal lung development associated with the diaphragmatic defect is responsible for the poor outcom
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Circular RNAs and their role in congenital diaphragmatic hernia
Seeking WiSDOM - a longitudinal population-based long-term follow-up study of congenital surgical anomalies
miRacles for abnormal lung development in congenital diaphragmatic hernia; defining the role of miR-200b
海外基金